Panray

Panray Corp. was a pharmaceutical company primarily known for its contributions to the treatment of tuberculosis and the production of specialty corticosteroids. As a division of Ormont Drug & Chemical Co., it manufactured widely used anti-TB medications such as Isoniazid (Panazid) and Pyrazinamide. The company also held approvals for various hormonal treatments, including cortisone and hydrocortisone tablets, and distributed medical devices like the Dermo-Jet needle-free injector. In recent years, the company became inactive, leading the FDA to withdraw its remaining drug applications in 2022 due to a failure to maintain regulatory reporting.